Sildenafilo oral como tratamiento de un neonato con hipertensión pulmonar persistente

Martínez Mengual, L; Parrondo Garrido, SM; Jerez Rojas, J; Rodríguez Fernández, A; Fernández González, N.
An. pediatr. (2003, Ed. impr.) ; 61(6): 567-568, dic. 2004.
Artículo en Es | IBECS (España) | ID: ibc-36845

Documentos relacionados

  1. Milrinone Versus Sildenafil in Treatment of Neonatal Persistent Pulmonary Hypertension: A Randomized Control Trial.
  2. Comparison of Different Treatments of Persistent Pulmonary Hypertension of the Newborn: A Systematic Review and Network Meta-Analysis.
  3. Management of neonatal pulmonary hypertension-a survey of neonatal intensive care units in India.
  4. Persistent Pulmonary Hypertension of the Newborn: Should Sildenafil and Inhaled Nitric Oxide at Medium Concentration Be the Standard of Treatment?
  5. RE: Efficacy and safety of IV sildenafil in the treatment of newborn infants with, or at risk of persistent pulmonary hypertension of the newborn (PPHN): A multicenter, randomized, placebo-controlled trial.
  6. Life-threatening PPHN refractory to nitric oxide: proposal for a rational therapeutic algorithm.
  7. Effects of Inhaled Iloprost for the Management of Persistent Pulmonary Hypertension of the Newborn.
  8. Treatment of Persistent Pulmonary Hypertension of the Newborn: Use of Pulmonary Vasodilators in Term Neonates.
  9. Use of sildenafil in an infant with persistent pulmonary hypertension secondary to lung and renal hypoplasia - a case report.
  10. A comparison of magnesium sulphate and sildenafil in the treatment of the newborns with persistent pulmonary hypertension: a randomized controlled trial.